Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 123

Similar articles for PubMed (Select 19035478)

1.

S100A12 is a novel molecular marker differentiating systemic-onset juvenile idiopathic arthritis from other causes of fever of unknown origin.

Wittkowski H, Frosch M, Wulffraat N, Goldbach-Mansky R, Kallinich T, Kuemmerle-Deschner J, Frühwald MC, Dassmann S, Pham TH, Roth J, Foell D.

Arthritis Rheum. 2008 Dec;58(12):3924-31. doi: 10.1002/art.24137.

2.

The myeloid-related proteins 8 and 14 complex, a novel ligand of toll-like receptor 4, and interleukin-1beta form a positive feedback mechanism in systemic-onset juvenile idiopathic arthritis.

Frosch M, Ahlmann M, Vogl T, Wittkowski H, Wulffraat N, Foell D, Roth J.

Arthritis Rheum. 2009 Mar;60(3):883-91. doi: 10.1002/art.24349.

3.

Neutrophil-derived S100A12 as novel biomarker of inflammation in familial Mediterranean fever.

Kallinich T, Wittkowski H, Keitzer R, Roth J, Foell D.

Ann Rheum Dis. 2010 Apr;69(4):677-82. doi: 10.1136/ard.2009.114363. Epub 2009 Sep 17.

PMID:
19762364
4.

Serum S100A12 and temporomandibular joint magnetic resonance imaging in juvenile idiopathic arthritis Egyptian patients: a case control study.

Abdul-Aziez OA, Saber NZ, El-Bakry SA, Mohammad AA, Abdel-Maksud SS, Ali Y.

Pak J Biol Sci. 2010 Feb 1;13(3):101-13.

5.

Validation of relapse risk biomarkers for routine use in patients with juvenile idiopathic arthritis.

Rothmund F, Gerss J, Ruperto N, Däbritz J, Wittkowski H, Frosch M, Wulffraat NM, Wedderburn LR, Holzinger D, Gohar F, Vastert SJ, Brik R, Deslandre CJ, Melo-Gomes JA, Saad Magalhaes C, Barcellona R, Russo R, Gattorno M, Martini A, Roth J, Foell D; Paediatric Rheumatology International Trials Organisation (PRINTO).

Arthritis Care Res (Hoboken). 2014 Jun;66(6):949-55.

PMID:
24339418
6.
7.

Acute Kawasaki disease is associated with reverse regulation of soluble receptor for advance glycation end products and its proinflammatory ligand S100A12.

Wittkowski H, Hirono K, Ichida F, Vogl T, Ye F, Yanlin X, Saito K, Uese K, Miyawaki T, Viemann D, Roth J, Foell D.

Arthritis Rheum. 2007 Dec;56(12):4174-81.

8.

Monitoring neutrophil activation in juvenile rheumatoid arthritis by S100A12 serum concentrations.

Foell D, Wittkowski H, Hammerschmidt I, Wulffraat N, Schmeling H, Frosch M, Horneff G, Kuis W, Sorg C, Roth J.

Arthritis Rheum. 2004 Apr;50(4):1286-95.

9.

Moderate performance of serum S100A12, in distinguishing inflammatory bowel disease from irritable bowel syndrome.

Manolakis AC, Kapsoritakis AN, Georgoulias P, Tzavara C, Valotassiou V, Kapsoritaki A, Potamianos SP.

BMC Gastroenterol. 2010 Oct 14;10:118. doi: 10.1186/1471-230X-10-118.

10.

HMGB1 levels are increased in patients with juvenile idiopathic arthritis, correlate with early onset of disease, and are independent of disease duration.

Schierbeck H, Pullerits R, Pruunsild C, Fischer M, Holzinger D, Laestadius Å, Sundberg E, Harris HE.

J Rheumatol. 2013 Sep;40(9):1604-13. doi: 10.3899/jrheum.120987. Epub 2013 Jul 15.

PMID:
23858044
11.

Phagocyte-derived S100 proteins in autoinflammation: putative role in pathogenesis and usefulness as biomarkers.

Kessel C, Holzinger D, Foell D.

Clin Immunol. 2013 Jun;147(3):229-41. doi: 10.1016/j.clim.2012.11.008. Epub 2012 Dec 7. Review.

PMID:
23269200
12.

Discrimination of acute lymphoblastic leukemia from systemic-onset juvenile idiopathic arthritis at disease onset.

Tamashiro MS, Aikawa NE, Campos LM, Cristofani LM, Odone-Filho V, Silva CA.

Clinics (Sao Paulo). 2011;66(10):1665-9.

13.

The presence of high mobility group box-1 and soluble receptor for advanced glycation end-products in juvenile idiopathic arthritis and juvenile systemic lupus erythematosus.

Bobek D, Grčević D, Kovačić N, Lukić IK, Jelušić M.

Pediatr Rheumatol Online J. 2014 Dec 3;12:50. doi: 10.1186/1546-0096-12-50. eCollection 2014.

14.

Tumor necrosis factor receptor-associated periodic syndrome mimicking systemic juvenile idiopathic arthritis.

Manki A, Nishikomori R, Nakata-Hizume M, Kunitomi T, Takei S, Urakami T, Morishima T.

Allergol Int. 2006 Sep;55(3):337-41.

15.
16.

Measurement and evaluation of isotypes of anti-citrullinated fibrinogen and anti-citrullinated alpha-enolase antibodies in juvenile idiopathic arthritis.

Moore TL, Gillian BE, Crespo-Pagnussat S, Feller L, Chauhan AK.

Clin Exp Rheumatol. 2014 Sep-Oct;32(5):740-6. Epub 2014 Jul 17.

PMID:
25068682
17.

Soluble ST2 as a marker of disease activity in systemic juvenile idiopathic arthritis.

Ishikawa S, Shimizu M, Ueno K, Sugimoto N, Yachie A.

Cytokine. 2013 May;62(2):272-7. doi: 10.1016/j.cyto.2013.03.007. Epub 2013 Apr 3.

PMID:
23561929
19.

Faecal S100A12 as a non-invasive marker distinguishing inflammatory bowel disease from irritable bowel syndrome.

Kaiser T, Langhorst J, Wittkowski H, Becker K, Friedrich AW, Rueffer A, Dobos GJ, Roth J, Foell D.

Gut. 2007 Dec;56(12):1706-13. Epub 2007 Aug 3.

20.

Soluble CD25 in serum: a potential marker for subclinical macrophage activation syndrome in patients with active systemic onset juvenile idiopathic arthritis.

Reddy VV, Myles A, Cheekatla SS, Singh S, Aggarwal A.

Int J Rheum Dis. 2014 Mar;17(3):261-7. doi: 10.1111/1756-185X.12196. Epub 2014 Jan 13.

PMID:
24417800
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk